Schedule 13G ownership disclosure

PMV PHARMACEUTICALS INC

Common stock, par value $0.00001 · CUSIP: 69353Y103

Event date: 2025-12-31

Filing-level shares
3,090,093.00
Percent of class
5.81%
  • ArrowMark Colorado Holdings, LLC

    Shares: 3,090,093.00 · Class: 5.81%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001172661-26-001163
Form type
SCHEDULE 13G/A
Filer
ArrowMark Colorado Holdings LLC
CIK
CIK 1483859
Filed
Feb 17, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub